上海電氣(601727.SH)漲超7% 領分拆概念股普漲
格隆匯12月16日丨A股市場分拆概念股普漲,其中,上海電氣(601727.SH)漲超7%,聯美控股和楚江新材漲超3%,和而泰、華邦健康均有一定程度的上漲。證監會上週五發布《上市公司分拆所屬子公司境內上市試點若干規定》,與徵求意見稿相比,主要區別在於降低分拆上市的淨利潤門檻、放寬募集資金使用要求、放寬子公司董事及高管持股要求等。其中,在分拆財務指標門檻上,正式規定從上市公司分拆後的三年累計淨利潤(扣非淨利潤孰低)不少於10億元降至不少於6億元。楚江新材近日稱將積極推動子公司分拆上市相關工作;華邦健康稱將積極推動凱盛新材、穎泰生物分拆上市工作;和而泰稱會積極研究分拆上市相關政策,根據實際情況和發展需要作出決策;上海電氣稱將加速推進分拆上市工作;聯美控股稱子公司兆訊傳媒符合分拆上市的各項指標,正在着手研究。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.